Gallium (68Ga) Oxodotreotide is a radiopharmaceutical somatostatin receptor ligand used in positron emission tomography to enable the precise localization and imaging of neuroendocrine tumors. By binding… Read more
Gallium (68Ga) Oxodotreotide is a radiopharmaceutical somatostatin receptor ligand used in positron emission tomography to enable the precise localization and imaging of neuroendocrine tumors. By binding specifically to receptors overexpressed on these tumor cells, this diagnostic agent facilitates accurate disease site identification. To ensure the reliability and safety of this diagnostic tool, analytical laboratories rely on high-quality reference standards, including the active pharmaceutical ingredient, its metabolites, and associated impurities. These compounds, such as piperazineethanesulfonic acid derivatives, are critical for impurity profiling, method validation, and rigorous quality control protocols. Access to precisely characterized reference materials supports the development and verification of sensitive analytical methods, ensuring that radiopharmaceutical preparations meet the required specifications for clinical diagnostic applications.